COFEPRIS-2021-0094-V394
Type IB variation for application COFEPRIS-2021-0094. Type IB variation: New Dosage Strength for Neprilozone — critical change
Variation Number
COFEPRIS-2021-0094-V394
Type
Type IB
Application
Change
Status
Pending
Fee
€4,022
Submitted
—
Approved
—
Description
Type IB variation: New Dosage Strength for Neprilozone — critical change